MX2013006066A - Inhibidor de quinasa janus 2 (jak2) para el tratamiento de lupus. - Google Patents
Inhibidor de quinasa janus 2 (jak2) para el tratamiento de lupus.Info
- Publication number
- MX2013006066A MX2013006066A MX2013006066A MX2013006066A MX2013006066A MX 2013006066 A MX2013006066 A MX 2013006066A MX 2013006066 A MX2013006066 A MX 2013006066A MX 2013006066 A MX2013006066 A MX 2013006066A MX 2013006066 A MX2013006066 A MX 2013006066A
- Authority
- MX
- Mexico
- Prior art keywords
- lupus
- jak2
- inhibitor
- treatment
- janus kinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Abstract
La presente invención proporciona un método para tratar lupus en un sujeto, que comprende la etapa de administrar al sujeto del Compuesto A (Ver Fórmula) Compuesto A.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42005310P | 2010-12-06 | 2010-12-06 | |
US42096710P | 2010-12-08 | 2010-12-08 | |
PCT/US2011/063427 WO2012078574A2 (en) | 2010-12-06 | 2011-12-06 | Janus kinase 2 (jak2) inhibitor for the treatment of lupus |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013006066A true MX2013006066A (es) | 2013-12-02 |
MX338595B MX338595B (es) | 2016-04-25 |
Family
ID=46207678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013006066A MX338595B (es) | 2010-12-06 | 2011-12-06 | Inhibidor de quinasa janus 2 (jak2) para el tratamiento de lupus. |
Country Status (8)
Country | Link |
---|---|
US (1) | US9023853B2 (es) |
EP (1) | EP2648728B1 (es) |
JP (1) | JP6033230B2 (es) |
CA (1) | CA2818941A1 (es) |
ES (1) | ES2582465T3 (es) |
HK (1) | HK1189822A1 (es) |
MX (1) | MX338595B (es) |
WO (1) | WO2012078574A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6046633B2 (ja) * | 2010-12-06 | 2016-12-21 | セファロン、インク. | 1,2,4−トリアゾロ[1,5a]ピリジン誘導体を用いた慢性炎症の治療 |
WO2017013270A1 (en) | 2015-07-23 | 2017-01-26 | Universite De Strasbourg | Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009029998A1 (en) * | 2007-09-06 | 2009-03-12 | Cytopia Research Pty Ltd | Retrometabolic compounds |
GB0719803D0 (en) * | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
JP5595389B2 (ja) * | 2008-06-20 | 2014-09-24 | ジェネンテック, インコーポレイテッド | トリアゾロピリジンjak阻害剤化合物と方法 |
JP5512665B2 (ja) * | 2008-06-20 | 2014-06-04 | ジェネンテック, インコーポレイテッド | トリアゾロピリジンjak阻害剤化合物と方法 |
GB0812198D0 (en) * | 2008-07-03 | 2008-08-13 | Xipower Ltd | Improvements in and relating to battery management |
WO2010010184A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
EP2438066A2 (en) * | 2009-06-05 | 2012-04-11 | Cephalon, Inc. | PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES |
JP6046633B2 (ja) * | 2010-12-06 | 2016-12-21 | セファロン、インク. | 1,2,4−トリアゾロ[1,5a]ピリジン誘導体を用いた慢性炎症の治療 |
-
2011
- 2011-12-06 WO PCT/US2011/063427 patent/WO2012078574A2/en active Application Filing
- 2011-12-06 JP JP2013542251A patent/JP6033230B2/ja active Active
- 2011-12-06 MX MX2013006066A patent/MX338595B/es active IP Right Grant
- 2011-12-06 ES ES11846725.7T patent/ES2582465T3/es active Active
- 2011-12-06 EP EP11846725.7A patent/EP2648728B1/en active Active
- 2011-12-06 CA CA2818941A patent/CA2818941A1/en not_active Abandoned
-
2013
- 2013-06-06 US US13/911,447 patent/US9023853B2/en active Active
-
2014
- 2014-03-26 HK HK14102962.4A patent/HK1189822A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012078574A9 (en) | 2012-08-16 |
EP2648728A4 (en) | 2014-06-04 |
EP2648728B1 (en) | 2016-04-27 |
WO2012078574A2 (en) | 2012-06-14 |
ES2582465T3 (es) | 2016-09-13 |
EP2648728A2 (en) | 2013-10-16 |
CA2818941A1 (en) | 2012-06-14 |
US20140024655A1 (en) | 2014-01-23 |
HK1189822A1 (zh) | 2014-06-20 |
MX338595B (es) | 2016-04-25 |
JP6033230B2 (ja) | 2016-11-30 |
JP2013544292A (ja) | 2013-12-12 |
US9023853B2 (en) | 2015-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX339873B (es) | Inhibidores de serina/treonina cinasa. | |
TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
MY165620A (en) | Cyclopropylamines as lsd1 inhibitors | |
MX340756B (es) | Compuestos de quinazolina como inhibidores de serina/treonina quinasa. | |
MY179607A (en) | Combinations of akt inhibitor compounds and abiraterone, and methods of use | |
EA201890768A2 (ru) | Лечение злокачественной опухоли ингибиторами tor-киназы | |
MX2018004832A (es) | Selectividad de mutante y combinaciones de un compuesto inhibidor de fosfoinositida 3 cinasa y agentes quimioterapeuticos para el tratamiento de cancer. | |
MY162933A (en) | Chemical compounds | |
MX2010002312A (es) | Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis. | |
UA115983C2 (uk) | Інгібітори днк-пк | |
IN2012DN03883A (es) | ||
WO2013134336A3 (en) | Inhibition of adaptor associated kinase 1 for the treatment of pain | |
MX2009005649A (es) | Tratamiento para mieloma multiple. | |
NZ723971A (en) | Methods and compositions for treating ewings sarcoma family of tumors | |
MX2015000980A (es) | Inhibidores de aril lactama cinasa. | |
UA115455C2 (uk) | Спосіб одержання сполук для застосування при лікуванні раку | |
PH12015501038A1 (en) | Inhibitors of iap | |
MX2013011333A (es) | Combinaciones de compuestos inhibidores de akt y mek, y metodos de uso. | |
MX343968B (es) | Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus. | |
JO3145B1 (ar) | مركبات مفيدة لتثبيط chk1 | |
WO2013037943A8 (en) | Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors | |
MX338595B (es) | Inhibidor de quinasa janus 2 (jak2) para el tratamiento de lupus. | |
MX2011012538A (es) | Terapia de combinacion para el tratamiento del mieloma multiple. | |
GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
UA42783U (ru) | Способ лечения дисбактериоза |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |